Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book
  1. Brieflands
  2. journals
  3. Archives of Neuroscience
  4. Articles

  5. Efficacy and Toxicity of Rituximab in Multiple Sclerosis
  6. Crossref

Archives of Neuroscience

Home
Current IssueAll IssuesIn PressAccepted ManuscriptsSearch
Instructions
Journal InformationEditor and BoardsIndexing and Listing SourcesJournal MetricsPublication Ethics and Malpractice StatementSupportContact UsReviewer and AE Registration FormOpen Peer Review (OPR)
APC
Authors GuideSubmit Manuscript

Crossref


1. Multiple sclerosis is accompanied by lack of KIR2DS1 gene: A meta-analysis

- Farhad Shahsavar

- Shaghayegh Mapar

- Seyyed Amir Yasin Ahmadi

2. New approach of using medicinal mushrooms for managing and curing multiple sclerosis

- Golchehr Pourmohammadi

- Hamid Moghimi

3. Neuroprotective Methodologies in the Treatment of Multiple Sclerosis Current Status of Clinical and Pre-clinical Findings

- Tarun Kapoor

- Sidharth Mehan

4. Pharmacotherapy of Prograf (Tacrolimus) in Liver Transplant Recipients; Consideration of Its' Levels with Efficacy and Toxicity

- Zahra Tolou-Ghamari

5. Infusion-Related, Short-term, and Delayed Side Effects of Rituximab in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder

- Farzane Farzadfard

- Maryam Poursadeghfard

- Nahid Ashjazadeh

HomeInstructionsAPC

Articles

  • Current Issue
  • All Issues
  • In Press
  • Accepted Manuscripts
  • Search

About Journal

  • Journal Information
  • Editor and Boards
  • Indexing and Listing Sources
  • Journal Metrics
  • Publication Ethics and Malpractice Statement
  • Support
  • Contact Us
  • Reviewer and AE Registration Form
  • Open Peer Review (OPR)
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.